Looking Into Patient Perspectives on Ocular Gene Therapy

Time: 12:35 pm
day: Day One Track B - Morning


  • Presenting on the VENTURE retinal disease natural history study
  • How to ensure potential recipients of gene therapy are phenotyped and genotyped early, in preparation for upcoming trials, and what are the barriers of knowledge uptake of emerging treatments?
  • Value of prospective longitudinal studies of the inherital retinal disease that treatments are being developed for